Gritstone bio Future Growth
Future criteria checks 2/6
Gritstone bio's earnings are forecast to decline at 8.1% per annum while its annual revenue is expected to grow at 55.7% per year. EPS is expected to grow by 6.2% per annum.
Key information
-8.1%
Earnings growth rate
6.2%
EPS growth rate
Biotechs earnings growth | 28.3% |
Revenue growth rate | 55.7% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 11 Oct 2024 |
Recent future growth updates
Recent updates
We Think Some Shareholders May Hesitate To Increase Gritstone bio, Inc.'s (NASDAQ:GRTS) CEO Compensation
Jun 11Gritstone bio: GRANITE Cancer Vaccine Data Overshadowed By Offering
Apr 07Gritstone bio, Inc. (NASDAQ:GRTS) Analysts Just Slashed This Year's Revenue Estimates By 40%
Aug 14Gritstone bio: Early Data For SLATE Candidate Sets Up 2023 Catalyst
Sep 26Gritstone reaches six-month high on publication of data for cancer vaccine
Aug 16Gritstone bio announces $80M credit facility
Jul 21Is Gritstone bio (NASDAQ:GRTS) In A Good Position To Invest In Growth?
Jul 07Gritstone bio: Potential To Advance Colorectal Cancer Treatment
Jul 05Gritstone bio: Investing In A Premium mRNA Technology At A Discounted Valuation
Jun 14Some Analysts Just Cut Their Gritstone bio, Inc. (NASDAQ:GRTS) Estimates
Mar 17We're Not Very Worried About Gritstone bio's (NASDAQ:GRTS) Cash Burn Rate
Mar 05Gritstone: Why The Stock Fell On Positive Data
Jan 18Gritstone bio (NASDAQ:GRTS) Is In A Strong Position To Grow Its Business
Nov 23Gritstone Poised To Dominate mRNA Market
Nov 08Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 16 | -176 | -146 | -104 | 3 |
12/31/2025 | 8 | -136 | -129 | -92 | 5 |
12/31/2024 | 9 | -115 | -118 | -85 | 5 |
6/30/2024 | 15 | -133 | -112 | -111 | N/A |
3/31/2024 | 16 | -145 | -118 | -115 | N/A |
12/31/2023 | 16 | -138 | -126 | -122 | N/A |
9/30/2023 | 10 | -139 | -138 | -133 | N/A |
6/30/2023 | 12 | -130 | -133 | -127 | N/A |
3/31/2023 | 15 | -125 | -128 | -123 | N/A |
12/31/2022 | 20 | -120 | -122 | -116 | N/A |
9/30/2022 | 19 | -118 | -115 | -109 | N/A |
6/30/2022 | 18 | -116 | -105 | -98 | N/A |
3/31/2022 | 16 | -112 | -101 | -95 | N/A |
12/31/2021 | 48 | -75 | -56 | -51 | N/A |
9/30/2021 | 46 | -72 | -57 | -52 | N/A |
6/30/2021 | 45 | -70 | -61 | -57 | N/A |
3/31/2021 | 42 | -71 | -58 | -55 | N/A |
12/31/2020 | 4 | -105 | -93 | -89 | N/A |
9/30/2020 | 4 | -106 | -95 | -86 | N/A |
6/30/2020 | 4 | -107 | -105 | -91 | N/A |
3/31/2020 | 4 | -103 | -104 | -89 | N/A |
12/31/2019 | 4 | -94 | -101 | -85 | N/A |
9/30/2019 | 5 | -84 | -88 | -76 | N/A |
6/30/2019 | 4 | -75 | -56 | -49 | N/A |
3/31/2019 | 3 | -69 | -49 | -42 | N/A |
12/31/2018 | 1 | -65 | -44 | -38 | N/A |
9/30/2018 | 0 | -65 | -46 | -40 | N/A |
6/30/2018 | N/A | -56 | -60 | -49 | N/A |
3/31/2018 | N/A | -47 | N/A | -44 | N/A |
12/31/2017 | N/A | -41 | N/A | -35 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GRTS is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: GRTS is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: GRTS is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: GRTS's revenue (55.7% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: GRTS's revenue (55.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GRTS's Return on Equity is forecast to be high in 3 years time